Scavestrogens protect IMR 32 cells from oxidative stress-induced cell death

被引:28
作者
Blum-Degen, D
Haas, M
Pohli, S
Harth, R
Römer, W
Oettel, M
Riederer, P
Götz, ME
机构
[1] Univ Wurzburg, Dept Psychiat, Clin Neurochem, D-8700 Wurzburg, Germany
[2] Jenapharm GMBH & Co KG, Jena, Germany
[3] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden
关键词
scavestrogens; steroids; Alzheimer's disease; radicals; Fenton reagent; oxidative stress; IMR; 32; neuroblastoma; glutathione;
D O I
10.1006/taap.1998.8503
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Oxidative stress is considered an important pathophysiological mechanism contributing to promote cell death in a broad variety of diseases including cardiovascular and neurodegenerative disorders. The so-called scavestrogens J811 and J861, structurally derived from 17 alpha-estradiol, are potent radical scavengers and inhibitors of iron-induced cell damage in vitro. In this study the potential cytoprotective effects of the scavestrogens J811 and J861 against Fenton reagent-induced cell damage (50 mu M FeSO4 plus 200 mu M H2O2) were compared with those of 17 alpha- and 17 beta-estradiol. Cell viability studies using Trypan blue staining showed that estradiols and scavestrogens at concentrations ranging from 0.1 to 10 mu M are able to protect IMR 32 neuroblastoma cells from Fenton-mediated death. In addition, these compounds decreased lipid peroxidation measured as thiobarbituric acid reactive substances and renormalize oxidative stress-increased intracellular glutathione levels. When given 6 h after the toxic stimulus, J811 and J861 rescued 60% of cells, whereas 17 alpha- and 17 beta-estradiol were ineffective. These results suggest that the scavestrogens J811 and J861 are powerful antioxidants capable of interfering with radical-mediated cell death in diseases known to be aggravated by reactive oxygen species. Such compounds may be useful in the development of novel treatments for stroke or neurodegenerative disorders. (C) 1998 Academic Press.
引用
收藏
页码:49 / 55
页数:7
相关论文
共 41 条
[1]   Estradiol-17 beta as an antioxidant: Some distinct features when compared with common fat-soluble antioxidants [J].
Ayres, S ;
Tang, MY ;
Subbiah, MTR .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1996, 128 (04) :367-375
[2]   HYDROGEN-PEROXIDE MEDIATES AMYLOID-BETA PROTEIN TOXICITY [J].
BEHL, C ;
DAVIS, JB ;
LESLEY, R ;
SCHUBERT, D .
CELL, 1994, 77 (06) :817-827
[3]   Neuroprotection against oxidative stress by estrogens: Structure-activity relationship [J].
Behl, C ;
Skutella, T ;
Lezoualch, F ;
Post, A ;
Widmann, M ;
Newton, CJ ;
Holsboer, F .
MOLECULAR PHARMACOLOGY, 1997, 51 (04) :535-541
[4]   17-BETA ESTRADIOL PROTECTS NEURONS FROM OXIDATIVE STRESS-INDUCED CELL-DEATH IN-VITRO [J].
BEHL, C ;
WIDMANN, M ;
TRAPP, T ;
HOLSBOER, F .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 216 (02) :473-482
[5]   2-hydroxy-4-glutathion-S-yl-17β-estradiol and 2-hydroxy-1-glutathion-S-yl-17β-estradiol produce oxidative stress and renal toxicity in an animal model of 17β-estradiol-mediated nephrocarcinogenicity [J].
Butterworth, M ;
Lau, SS ;
Monks, TJ .
CARCINOGENESIS, 1998, 19 (01) :133-139
[6]   Formation of catechol estrogen glutathione conjugates and gamma-glutamyl transpeptidase-dependent nephrotoxicity of 17 beta-estradiol in the golden Syrian hamster [J].
Butterworth, M ;
Lau, SS ;
Monks, TJ .
CARCINOGENESIS, 1997, 18 (03) :561-567
[7]  
DARWISH H, 1991, J BIOL CHEM, V266, P551
[8]  
DIAZBRINTON R, 1997, NEUROCHEM RES, V22, P1339
[9]  
FERREIRA A, 1991, J NEUROSCI, V11, P392
[10]  
Good PF, 1996, AM J PATHOL, V149, P21